On May 20, 2022, Dennis P. Reilly, chief financial officer of Agile Therapeutics, Inc., notified the company that he will voluntarily resign from his position in order to retire. The company expects Mr. Reilly's resignation to be effective on May 31, 2022. Mr. Reilly will not receive any severance or other compensation payments in connection with his resignation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | 0.00% | +5.26% | -79.49% |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
1st Jan change | Capi. | |
---|---|---|
-79.49% | 2.74M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Agile Therapeutics, Inc. Announces Resignation of Dennis P. Reilly as Chief Financial Officer, Effective May 31, 2022